A Phase III prospective, interventional, cohort, superiority study to evaluate the benefit of rapid COVID-19 genomic sequencing (the COVID-19 GENOMICS UK Project) on infection control in preventing the spread of the virus in UK NHS hospitals
Latest Information Update: 23 Feb 2022
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Acronyms COG-UK HOCI
Most Recent Events
- 30 Aug 2021 New trial record
- 19 Aug 2021 Results (n=592) of a case-control study and genomic analysis using data from this trial published in the Clinical Infectious Diseases